Momenta Pharmaceuticals, Inc. (MNTA)
Q1 2012 Earnings Call
May 3, 2012 10:00 AM ET
Lora Pike – Senior Director, IR and Corporate Communications
Craig Wheeler – President and CEO
Rick Shea – SVP and CFO
Sapna Srivastava – Goldman Sachs
Ritu Baral – Canaccord
Sumant Kulkarni – Bank of America
Eric Schmidt – Cowen & Company
Joseph Schwartz – Leerink Swann
Good day, ladies and gentlemen and thank you for your patience. You’ve joined the Momenta Pharmaceuticals First Quarter 2012 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. (Operator Instructions) As a reminder, this conference may be recorded.
I would now like to turn the call over to your host, the Senior Director of Investor Relations and Corporate Communications, Ms. Lora Pike. Ma’am, you may begin.
Thank you and good morning, everyone. I want to welcome all of you to Momenta’s conference call to discuss financial results for the first quarter of 2011. With me on the call today with prepared remarks are Craig Wheeler, President and Chief Executive Officer, who will provide an update on our major programs. Followed by Rick Shea, Chief Financial Officer who will review our first quarter results and comment on our plans to reinvest in the company to drive future growth. Also joining us today for the Q&A portion of the call is Dr. Jim Roach, our Chief Medical Officer.